mgcd0103
Showing 1 - 10 of 10
Hodgkin's Lymphoma Trial in Canada, United States (MGCD0103)
Terminated
- Hodgkin's Lymphoma
- MGCD0103
-
Chicago, Illinois
- +4 more
Jun 5, 2015
Lymphoma Trial in Canada, United States (MGCD0103)
Completed
- Lymphoma
- MGCD0103
-
Durham, North Carolina
- +4 more
Jun 4, 2015
Myelodysplastic Syndrome, Acute Myelogenous Leukemia Trial in United States (MGCD0103)
Completed
- Myelodysplastic Syndrome
- Acute Myelogenous Leukemia
- MGCD0103
-
Los Angeles, California
- +7 more
Jun 4, 2015
Lymphocytic Leukemia, Chronic Trial in Canada, United States (MGCD0103)
Completed
- Lymphocytic Leukemia, Chronic
- MGCD0103
-
Kansas City, Missouri
- +12 more
Jun 4, 2015
Myelogenous Leukemia, Acute, MDS Trial in Canada, United States (MGCD0103)
Terminated
- Myelogenous Leukemia, Acute
- Myelodysplastic Syndromes
- MGCD0103
-
Kansas City, Missouri
- +12 more
Jun 4, 2015
Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in Canada, United Kingdom, United States (Azacitidine,
Terminated
- Acute Myeloid Leukemia (AML)
- Myelodysplastic Syndrome (MDS)
- Azacitidine
- MGCD0103
-
Houston, Texas
- +7 more
Apr 22, 2015
Leukemia, MDS Trial in Canada, United States (MGCD0103)
Completed
- Leukemia
- Myelodysplastic Syndromes
- MGCD0103
-
Tampa, Florida
- +3 more
Jan 6, 2015
Leukemia, MDS Trial in Houston, Toronto, Montreal (MGCD0103)
Completed
- Leukemia
- Myelodysplastic Syndromes
- MGCD0103
-
Houston, Texas
- +2 more
Jan 6, 2015
Tumors, Non Hodgkin's Lymphoma Trial in Baltimore, Toronto, Greenfield Park (MGCD0103)
Completed
- Tumors
- Non Hodgkin's Lymphoma
- MGCD0103
-
Baltimore, Maryland
- +2 more
Jan 6, 2015